A Phase I Trial of Gemcitabine Administered as a 96-h Continuous Intravenous Infusion in Patients with Advanced Carcinoma and Lymphoma

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 369-376

Humana Press, Inc

Access to resources Recommend Favorite

A Phase I Trial of 5-day Chronomodulated Infusion of 5-Fluorouracil and 1-Folinic Acid in Patients with Metastatic Colorectal Cancer

By Garufi C.   Levi F.   Aschelter A.M.   Pace R.   Giunta S.   Nistico C.   Galla D.A.P.   Silecchia G.F.   Franchi F.   Narduzzi C.   Terzoli E.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1566-1571

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Fixed Dose Rate Infusion Gemcitabine with Gefitinib in Patients with Pancreatic Carcinoma

By Carneiro Benedito A.   Brand Randall E.   Fine Elita   Knop Richard H.   Khandekar Janardan D.   Uhlig William   Locker Gershon Y.  

Cancer Investigation, Vol. 25, Iss. 5, 2007-07 ,pp. : 366-371

Informa Healthcare

Access to resources Recommend Favorite

Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement

By Tsimberidou Apostolia   Moulder Stacy   Fu Siqing   Wen Sijin   Naing Aung   Bedikian Agop   Daring Shawn   Uehara Cynthia   Ng Chaan   Wallace Michael   Camacho Luis   Kurzrock Razelle  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1087-1093

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine

By Cohen L.   de Moor C.   Parker P.A.   Amato R.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 3, 2002-05 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite